Glucal (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Glucose)

Glucal may be considered in situations where electrolyte and fluid balance need to be supported. Typical contexts include:

• Oral rehydration for mild dehydration.
• Supplementation of potassium and sodium in patients with electrolyte loss.
• Adjunct therapy for metabolic acidosis when oral administration is appropriate.
• Provision of glucose for energy during short-term fasting or mild hypoglycemia.
• Support during gastrointestinal illnesses that cause electrolyte disturbances.

Side effects of Glucal can vary in frequency and severity. Common reactions are generally mild, while serious events are rare but require medical attention.

Common

• Mild gastrointestinal discomfort such as nausea or abdominal bloating.
• Transient taste alteration.
• Mild headache.
• Temporary increase in urine output.

Serious

• Hyperkalemia (elevated potassium levels).
• Hypernatremia (elevated sodium levels).
• Severe metabolic alkalosis.
• Allergic skin reactions such as rash or urticaria.

When considering Glucal, several safety considerations should be observed:

• Assess baseline electrolyte levels before initiating therapy.
• Use caution in patients with renal impairment or heart failure.
• Monitor for signs of fluid overload, especially in the elderly.
• Avoid use in individuals with known hypersensitivity to any component.
• Pregnant or breastfeeding persons should consult a healthcare professional before use.
• Store at room temperature, protected from moisture and direct sunlight.

Glucal may interact with other medications or substances. Some combinations should be avoided, while others require careful monitoring.

Avoid

• Concomitant use with potassium-sparing diuretics that may increase potassium levels.
• Use with sodium bicarbonate-containing antacids, which could exacerbate alkalosis.

Use with caution

• Concurrent administration of ACE inhibitors or ARBs, which affect potassium balance.
• Combination with other electrolyte supplements, requiring monitoring of serum levels.
• Use alongside insulin or oral hypoglycemic agents, as glucose content may affect blood sugar control.